NASDAQ : AZRX

AzurRx BioPharma, Inc.

$3.45 USD

$0.07 (2.07%)

Volume
629.03K
Average Volume
713.03K
Market Capitalization
$3.43M
P/E Ratio
-0.73
Dividend Yield
0.00%
Price Target
Year High
$26.30
Year Low
$2.68
Day High
—
Day Low
—
Payout Ratio
-$0.04
Current Ratio
$0.16
Company Overview

NASDAQ

James Sapirstein

Biotechnology

Healthcare

AZRX

12

US

USD

https://enterothera.com

16466997855

05502L105

0001604191

Liquidity Metrics

0.11

0.16

0.16

0.02

-0.04

Sales & Valuation

$36251

46.10

0.65

-0.51

-1.50

Profitability

-$4.16

-$6.55M

-11728.15%

-11728.15%

-49.81%

-18.21%

P/E Metrics

-0.73

0.01

0.01

Analyst Price Target & Rating

N/A

0/5

4 Analysts

%

Financial Health Scores

-6.39

3/9

-$13.65M

$47.97M

$20.47M

$630.27K

Key Metrics (TTM)

$5.54M

74.38

3.11

0.16

-49.81%

-28.86%

-56.86%

-194.33%

9210 days

Company Executives

No executive data available.

Poll Results

No votes yet today — be the first to share your view!

About AzurRx BioPharma, Inc. (NASDAQ:AZRX) Stock

AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by res ... istant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).

Frequently Asked Questions

What is the current AzurRx BioPharma, Inc. (AZRX) stock price?

AzurRx BioPharma, Inc.(NASDAQ:AZRX) stock price is $3.45 in the last trading session. During the trading session, AZRX stock reached the peak price of $3.66 while $3.38 was the lowest point it dropped to. The percentage change in AZRX stock occurred in the recent session was 2.07% while the dollar amount for the price change in AZRX stock was $0.07.

AZRX's industry and sector of operation?

The NASDAQ listed AZRX is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of AZRX?

|
|
|
|
|

How many employees does AZRX have?

Number of AZRX employees currently stands at 12. AZRX operates from 760 Parkside Ave Ste 304, Brooklyn, NY 11226, US.

Link for AZRX official website?

Official Website of AZRX is: https://enterothera.com

How do I contact AZRX?

AZRX could be contacted at phone #16466997855 and can also be accessed through its website. AZRX operates from 760 Parkside Ave Ste 304, Brooklyn, NY 11226, US.

How many shares of AZRX are traded daily?

The average number of AZRX shares traded daily for last 3 months was 713.03K.

What is the market cap of AZRX currently?

The market value of AZRX currently stands at $3.43M with its latest stock price at $3.45